Department of Emergency Surgery, Cagliari University Hospital "Duilio Casula", Azienda Ospedaliero-Universitaria di Cagliari, Cagliari, Italy.
Policlinico Universitario di Monserrato "Duilio Casula", University of Cagliari, SS 554, Km 4,500, 09042, Monserrato, Italy.
Int J Colorectal Dis. 2021 Mar;36(3):589-598. doi: 10.1007/s00384-021-03843-8. Epub 2021 Jan 17.
The aim of this prospective multicenter study was to compare antibiotic therapy and appendectomy as treatment for patients with uncomplicated appendicitis confirmed by ultrasound and/or computed tomography.
The study was conducted from January 2017 to January 2018. Data regarding all patients discharged from the participating centers with a diagnosis of uncomplicated appendicitis were collected prospectively.
Of the 318 patients enrolled in the study, 27.4% underwent antibiotic-first therapy, and 72.6% underwent appendectomy. The matched group was composed of 87 patients in both study arms. Of the 87 patients available of 1-year follow-up in the antibiotic-first group, 64 (73.6%) did not require appendectomy. The complication-free treatment success in the antibiotic-first group was 64.4%. A statistically significant higher complication-free treatment success was found in the appendectomy group: 81.8% in the pre-matching sample and 83.9% in the post-matching sample. Patients in the antibiotic-first group reported lower VAS scores compared to those treated with an appendectomy, both at discharge (2.0 ± 1.7 vs 3.6 ± 2.3) and at 30-day follow-up (0.3 ± 0.6 vs 2.1 ± 1.7). The mean of the days of absence from work was higher in the appendectomy group (β 0.63; 95% CI 0.08-1.18).
Although laparoscopic appendectomy remains the gold standard of treatment for uncomplicated appendicitis, conservative treatment with antibiotics is a safe option in most cases. Approximately 65% of patients treated with antibiotics are symptom-free at 1 year, without increased risk of adverse events should symptoms recur, and better outcomes in terms of less pain and shorter period of absence from work compared to patients undergoing an appendectomy.
Clinicaltrials.gov identifier (NCT number): NCT03080103.
本前瞻性多中心研究旨在比较超声和/或计算机断层扫描确诊的单纯性阑尾炎患者的抗生素治疗和阑尾切除术治疗。
本研究于 2017 年 1 月至 2018 年 1 月进行。前瞻性收集了参加中心所有诊断为单纯性阑尾炎并出院患者的数据。
在纳入研究的 318 例患者中,27.4%接受了抗生素首治,72.6%接受了阑尾切除术。匹配组中,研究组和对照组各有 87 例患者。在接受抗生素首治的 87 例患者中,有 1 年随访结果的患者有 87 例,其中 64 例(73.6%)无需行阑尾切除术。抗生素首治组无并发症治疗成功率为 64.4%。在阑尾切除术组中发现无并发症治疗成功率更高:未匹配前为 81.8%,匹配后为 83.9%。与接受阑尾切除术的患者相比,接受抗生素首治的患者在出院时(2.0±1.7 对 3.6±2.3)和 30 天随访时(0.3±0.6 对 2.1±1.7)的 VAS 评分均较低。阑尾切除术组的缺勤天数平均值较高(β 0.63;95%CI 0.08-1.18)。
尽管腹腔镜阑尾切除术仍然是单纯性阑尾炎的金标准治疗方法,但在大多数情况下,使用抗生素的保守治疗是一种安全的选择。接受抗生素治疗的患者中,约有 65%在 1 年内无症状,且如果症状再次出现,不会增加不良事件的风险,并且与接受阑尾切除术的患者相比,疼痛更少,缺勤时间更短。
Clinicaltrials.gov 标识符(NCT 编号):NCT03080103。